Empowering biologics delivery

Croda Pharma is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations.

Among many sites, Croda’s Princeton, NJ site is the company’s centre of commercial innovation in North America. Strategically located along the east coast, this facility supports the pharmaceutical hub within the North American region. Home to our Cell and Tissue Culture Facility, our Princeton site and teams empower biologic delivery.

Croda Pharma’s formulation and regulation expertise enables the next generation of drug delivery systems. We offer high purity pharmaceutical excipients to enhance delivery, efficacy and stability of actives as well as highly performing vaccine adjuvants and in-house formulation expertise to aid in navigating drug and vaccine formulation challenges.

With a product profile proven to stabilise, solubilise and to deliver the most challenging of active pharmaceutical ingredients and a substantial investment in GMP and multi-site EXCiPACT accreditation, Croda Pharma demonstrates confidence in both excipient quality and supply chain security.